Description

Pancreatic Kininogenase is an enzyme preparation derived from pancreatic tissue that promotes vasodilation and improves microcirculation. Widely studied in experimental models of diabetic nephropathy, retinopathy, neuropathy, ischemic cerebrovascular disorders, and hypertension-related complications

Xiang’erkang’s injectable formulation contains 10 units per vial and is packaged as 10 vials per box. It is manufactured by Wuzhi Weierkang Biochemical Pharmaceutical Co., Ltd. and holds China NMPA approval number H37022182, product code 86903984000397 .

For Laboratory Research Use Only. Not for diagnostic, therapeutic, or veterinary applications.

Product Specifications

Mechanism & Research Applications

Pancreatic Kininogenase enhances microvascular perfusion by promoting vasodilation and reducing inflammation, improving blood flow in ischemic and neuropathic tissue .

Common research applications include:

• Diabetic microvascular disease models (nephropathy, neuropathy, retinopathy)

• Ischemic cerebrovascular and ocular disease studies

• Hypertension-related microcirculatory modeling

• Inflammation and endothelial function assays

Safety & Handling

• Use Restriction: Research Use Only (RUO). Not for human, clinical, or veterinary use

• Protective Gear: Wear gloves, lab coat, and goggles during reconstitution and handling

• Reconstitution: Add sterile water for injection and administer per experimental protocol

• Storage: Keep in cool, dry conditions; avoid heat and humidity

• Disposal: Follow institutional biosafety and chemical disposal regulations

Research Use Disclaimer

This product is intended exclusively for laboratory research purposes. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose safety or legal risks. Always adhere to institutional biosafety standards and ethical guidelines.